These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15550968)

  • 1. [P-glycoprotein--a pump of significance for drug response].
    Molden E
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2921-3. PubMed ID: 15550968
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of P-glycoprotein in pharmacokinetics and its clinical implications].
    Su CY
    Yao Xue Xue Bao; 2005 Aug; 40(8):673-9. PubMed ID: 16268498
    [No Abstract]   [Full Text] [Related]  

  • 3. Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).
    Hodges LM; Markova SM; Chinn LW; Gow JM; Kroetz DL; Klein TE; Altman RB
    Pharmacogenet Genomics; 2011 Mar; 21(3):152-61. PubMed ID: 20216335
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance in epilepsy: why is a simple explanation not enough?
    Löscher W; Sills GJ
    Epilepsia; 2007 Dec; 48(12):2370-2. PubMed ID: 18088269
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacogenomics of P-glycoprotein and its role in veterinary medicine.
    Martinez M; Modric S; Sharkey M; Troutman L; Walker L; Mealey K
    J Vet Pharmacol Ther; 2008 Aug; 31(4):285-300. PubMed ID: 18638289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of drug transporter for the internal medicine clinic].
    Siegmund W; Cascorbi I; Weitschies W; Kroemer HK
    Internist (Berl); 2003 Feb; 44(2):219-26. PubMed ID: 12674742
    [No Abstract]   [Full Text] [Related]  

  • 8. Current evidence for a genetic modulation of the response to analgesics.
    Lötsch J; Geisslinger G
    Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
    [No Abstract]   [Full Text] [Related]  

  • 9. P-glycoprotein activity and biological response.
    Vaalburg W; Hendrikse NH; Elsinga PH; Bart J; van Waarde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):257-60. PubMed ID: 16043202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles.
    Blackhall WJ; Prichard RK; Beech RN
    Vet Parasitol; 2008 Mar; 152(1-2):101-7. PubMed ID: 18241994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 pharmacogenetics: progress, pitfalls, and promise.
    Chinn LW; Kroetz DL
    Clin Pharmacol Ther; 2007 Feb; 81(2):265-9. PubMed ID: 17259950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.
    Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P
    Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507
    [No Abstract]   [Full Text] [Related]  

  • 13. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
    Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
    Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics: using DNA to optimize drug therapy.
    Lanfear DE; McLeod HL
    Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
    Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
    Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and lung transplantation: clinical implications.
    Burckart GJ; Hutchinson IV; Zeevi A
    Pharmacogenomics J; 2006; 6(5):301-10. PubMed ID: 16520825
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.
    Cressey TR; Lallemant M
    Infect Genet Evol; 2007 Mar; 7(2):333-42. PubMed ID: 17045554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey.
    Ozgon GO; Bebek N; Gul G; Cine N
    Eur Neurol; 2008; 59(1-2):67-70. PubMed ID: 17917461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.